News & Articles

Increasing Portuguese market presence by enhancing sales and after-sales support networks

Join us on Friday, February 26, to find out how to effectively profile the host response to COVID-19 infection using the next-generation automated ELISA, Ella

Find out how to overcome the challenges involved with establishing reference intervals for clinical interpretation in this on-demand webinar

New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific

The integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs

Take a look back at the technologies, innovations and clinical advances that hit the headlines over the past 12 months

Watch this on-demand webinar to find out how targeting B-cell maturation antigen and GPRC5D simultaneously could help to prevent tumor cell escape

Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing

Which new products made the most difference to your lab work this year?

The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance

Watch this webinar on demand to learn about the host immune response to COVID-19

Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication

Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies

Find out how to rapidly test for multiple disease-causing microorganisms with syndromic panel-based testing

Promega and Incyte intend to work together in the future to develop the Promega OncoMate MSI Assay as a companion diagnostic

The new line aims to provide unmatched sensitivity, resolution, speed, and flexibility of colors

The technology is said to be superior at identifying cell types in human blood, providing faster and more reliable assessments for clinical decision making

New indication allows this first FDA-approved biomarker-based test to be used as triage for positive cobas HPV tests run on cobas 6800/8800 Systems in primary screening or co-testing programs